Sandra F. Falkenhein

Author

Howard Hughes Medical Institute

Also Known As

S F Falkenhein, S Falkenhein, S. F. Falkenhein, S.F. Falkenhein, Sandra F. Falkenhein, Sandra Falkenhein

Publications

620

Citations

H-Index

Concepts

All Affiliations

Howard Hughes Medical Institute Washington University in St. Louis

About

Sandra F. Falkenhein is an author at Howard Hughes Medical Institute specializing in biochemistry, medicine, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Biochemistry	8	8	570
2	Medicine	7	7	530
3	Natural Sciences	4	4	174
4	Engineering	2	2	28
5	Allergy	2	2	104

Sandra F. Falkenhein

Publications

613

Citations

H-Index

Page 1

	Year	Citations
Precursor role of arachidonic acid in release of slow reacting substance from rat basophilic leukemia cells. Barbara A. Jakschik, Sandra F. Falkenhein, C W Parker Proceedings of the National Academy of Sciences Molecular PharmacologyOxysterolArachidonic Acid MetabolismBiochemistryMedicine	1977	184
Release of arachidonic acid from human lymphocytes in response to mitogenic lectins. C W Parker, James P. Kelly, Sandra F. Falkenhein, The Journal of Experimental Medicine InflammationHuman LymphocytesFree Arachidonic AcidAllergyBiochemistry	1979	91
Sequential conversion of the glutathionyl side chain of slow reacting substance (SRS) to cysteinyl-glycine and cysteine in rat basophilic leukemia cells stimulated with A-23187 Charles W. Parker, Sandra F. Falkenhein, Mary Huber Prostaglandins Aldo-keto ReductaseGlutathionyl Side ChainBiochemistrySequential ConversionMedicine	1980	82
Characterization of the two major species of slow reacting substance from rat basophilic leukemia cells as glutathionyl thioethers of eicosatetraenoic acids oxygenated at the 5 position. Evidence that peroxy groups are present and important for spasmogenic activity Charles W. Parker, Mary Huber, Michael K. Hoffman, Prostaglandins BiochemistryMajor SpeciesMedicineSpasmogenic ActivityLipid Peroxidation	1979	71
Formation of the cysteinyl form of slow reacting substance (leukotriene E4) in human plasma Charles W. Parker, Del A. Koch, Mary Huber, Biochemical and Biophysical Research Communications BiochemistryMedicinePhysiologyLeukotriene E4Human Plasma	1980	50
Effect of the 5-hydroperoxide of eicosatetraenoic acid and inhibitors of the lipoxygenase pathway on the formation of slow reacting substance by rat basophilic leukemia cells; direct evidence that slow reacting substance is a product of the lipoxygenase pathway. Sandra F. Falkenhein, H. Robson MacDonald, Mary Huber, The Journal of Immunology Lipid PeroxidationRedox BiologyOxidative StressMedicinal ChemistryBiosynthesis	1980	39
Characterization of slow reacting substance as a family of thiolipids derived from arachidonic acid Charles W. Parker, Barbara A. Jakschik, Mary G. Huber, Biochemical and Biophysical Research Communications BiochemistryNatural SciencesArachidonic AcidChemical BiologyPharmacology	1979	37
Suggestive Evidence for Both Stimulatory and Inhibitory Domains on Human Lymphocytes, as Indicated by Phospholipid Turnover Studies with Wheat Germ Agglutinin and Other Lectins C W Parker, R. E. Dankner, Sandra F. Falkenhein, Immunological Communications	1976	18
Arylsulfatase inactivation of slow reacting substance. Evidence for proteolysis as a major mechanism when ordinary commercial preparations of the enzyme are used Charles W. Parker, Del A. Koch, Mary Huber, Prostaglandins EnzymologyEngineeringBiochemistryMajor MechanismOrdinary Commercial Preparations	1980	16
Induction of Ige Receptors on Human Lymphocytes Charles W. Parker, Teresa Schechtel, Sandra F. Falkenhein, Immunological Communications AllergyAutoimmune DiseaseMedicineImmune RegulationImmunology	1983	13

Page 1